Beatson Oncology Centre

Glasgow G12 0YN

0 studies enrolling now · 12 studies all time

What they study most

Carcinoid Tumor of the Small Bowel, Carcinoma, Non-Small-Cell Lung, Clear Cell Renal Carcinoma, Endometrial Neoplasms, Gastric Adenocarcinoma, Gastroesophageal Adenocarcinoma, Head and Neck Cancer, MPN-associated Myelofibrosis, Malignant Pleural Mesothelioma, Neuroendocrine Tumour, Ovarian Cancer, Ovarian Neoplasms

Studies at this site

• The BURAN Study of Buparlisib in Patients With Recurrent or Metastatic HNSCC — Completed
• Efficacy and Safety of Farletuzumab (MORAb-003) in Combination With Carboplatin and Taxane in Participants With Platinum-sensitive Ovarian Cancer in First Relapse — Stopped early
• A Study Comparing Treatment With 177Lu-DOTA0-Tyr3-Octreotate to Octreotide LAR in Patients With Inoperable, Progressive, Somatostatin Receptor Positive Midgut Carcinoid Tumours — Completed
• TroVax Renal Immunotherapy Survival Trial — Completed
• Study of Pomalidomide in Persons With Myeloproliferative-Neoplasm-Associated Myelofibrosis and RBC-Transfusion-Dependence — Completed
• A Study Of Two Dual PI3K/mTOR Inhibitors, PF-04691502 And PF-05212384 In Patients With Recurrent Endometrial Cancer — Stopped early
• Placebo Controlled Study of VS-6063 in Subjects With Malignant Pleural Mesothelioma — Stopped early
• Erlotinib (Tarceva) as a Single Agent or Intercalated With Combination Chemotherapy in Patients With EGFR Positive NSCLC — Completed
• Study of OSI-211 vs. Topotecan in Patients With Relapsed Epithelial Ovarian Cancer — Completed
• TLK286 (Telcyta) vs. Doxil/Caelyx or Hycamtin in Platinum Refractory or Resistant Ovarian Cancer — Completed
• GVAX® Vaccine for Prostate Cancer vs Docetaxel & Prednisone in Patients With Metastatic Hormone-Refractory Prostate Cancer — Stopped early
• Phase II Study of Single Agent OSI-7904L in Patients With Gastric or Gastroesophageal (GEJ) Cancer — Completed